Assessment of Everolimus in Addition to Calcineurin Inhibitors Reduction in Maintenance Renal Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 03 Feb 2015
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms ASCERTAIN
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 21 Apr 2012 Planned number of patients changed from 395 to 490 as reported by European Clinical Trials Database record.
- 21 Jun 2011 Primary endpoint 'Glomerular-filtration-rate' has not been met, as published in Transplantation.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History